The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of serplulimab combined with gemcitabine plus nab-paclitaxel (GnP) and SBRT for metastatic pancreatic cancer as the first-line treatment.
 
Ke Cheng
No Relationships to Disclose
 
Chenyan Zhang
No Relationships to Disclose
 
Gang Zhao
No Relationships to Disclose
 
Xiaoying Li
No Relationships to Disclose
 
Jiaxin Liu
No Relationships to Disclose
 
Zhiping Li
No Relationships to Disclose
 
Heqi Yang
No Relationships to Disclose
 
Bole Tian
No Relationships to Disclose
 
Chengjian Zhao
No Relationships to Disclose
 
Dan Cao
No Relationships to Disclose